These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26774689)

  • 1. Two-fold illumination in topical 5-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) for superficial basal cell carcinoma (sBCC): A retrospective case series and cohort study.
    Kessels J; Hendriks J; Nelemans P; Mosterd K; Kelleners-Smeets N
    J Am Acad Dermatol; 2016 May; 74(5):899-906. PubMed ID: 26774689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.
    Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K
    J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial.
    de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ; de Haas ER
    Acta Derm Venereol; 2012 Nov; 92(6):641-7. PubMed ID: 22964973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
    de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy.
    de Haas ER; Kruijt B; Sterenborg HJ; Martino Neumann HA; Robinson DJ
    J Invest Dermatol; 2006 Dec; 126(12):2679-86. PubMed ID: 16841035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU).
    Roozeboom MH; van Kleef L; Arits AH; Mosterd K; Winnepenninckx VJ; van Marion AM; Nelemans PJ; Kelleners-Smeets NW
    J Am Acad Dermatol; 2015 Jul; 73(1):93-8. PubMed ID: 25935596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
    Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial.
    Kessels JPHM; Kreukels H; Nelemans PJ; Roozeboom MH; van Pelt H; Mosterd K; de Haas ERM; Kelleners-Smeets NWJ
    Br J Dermatol; 2018 May; 178(5):1056-1063. PubMed ID: 28886209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non-melanoma skin cancers.
    Tarstedt M; Gillstedt M; Wennberg Larkö AM; Paoli J
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):420-3. PubMed ID: 26841041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
    Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
    Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Efficacy of Photodynamic Therapy with Fractionated 5-Aminolevulinic Acid 20% versus Conventional Two-Stage Topical Methyl Aminolevulinate for Superficial Basal-Cell Carcinoma.
    van Delft LCJ; Nelemans PJ; Kessels JPHM; Kreukels H; Roozeboom MH; de Rooij MJM; Mosterd K; de Haas ERM; Kelleners-Smeets NWJ
    Dermatology; 2022; 238(6):1044-1049. PubMed ID: 35598594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial.
    Roozeboom MH; Nelemans PJ; Mosterd K; Steijlen PM; Arits AH; Kelleners-Smeets NW
    Br J Dermatol; 2015 Mar; 172(3):739-45. PubMed ID: 25066012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up.
    Szeimies RM; Ibbotson S; Murrell DF; Rubel D; Frambach Y; de Berker D; Dummer R; Kerrouche N; Villemagne H;
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1302-11. PubMed ID: 18624836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-aminolevulinic acid based photodynamic therapy for basal cell carcinoma: a 10-years follow-up study.
    Griškjans Ž; Derjabo A; Čēma I
    Stomatologija; 2013; 15(1):32-6. PubMed ID: 23732828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical 5-aminolevulinic acid mediated photodynamic therapy of superficial basal cell carcinoma using two light fractions with a two-hour interval: long-term follow-up.
    Star WM; van't Veen AJ; Robinson DJ; Munte K; de Haas ER; Sterenborg HJ
    Acta Derm Venereol; 2006; 86(5):412-7. PubMed ID: 16955185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy for cutaneous squamous cell carcinoma in situ: Impact of anatomic location, tumor diameter, and incubation time on effectiveness.
    Kibbi N; Zhang Y; Leffell DJ; Christensen SR
    J Am Acad Dermatol; 2020 May; 82(5):1124-1130. PubMed ID: 31712171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma.
    Morton CA; Whitehurst C; McColl JH; Moore JV; MacKie RM
    Arch Dermatol; 2001 Mar; 137(3):319-24. PubMed ID: 11255332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study.
    Christensen E; Mørk C; Skogvoll E
    Br J Dermatol; 2012 Jun; 166(6):1342-8. PubMed ID: 22309486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma.
    Rhodes LE; de Rie MA; Leifsdottir R; Yu RC; Bachmann I; Goulden V; Wong GA; Richard MA; Anstey A; Wolf P
    Arch Dermatol; 2007 Sep; 143(9):1131-6. PubMed ID: 17875873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of superficial basal cell carcinoma with photodynamic therapy. Observational study in 22 patients with 5-aminolaevulinic acid and methyl aminolaevulinate.
    Alique-García S; Company-Quiroga J; Sánchez Campos A; Hernández Núñez A; Borbujo J
    Photodiagnosis Photodyn Ther; 2019 Jun; 26():190-192. PubMed ID: 30914392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.